NasdaqGS:DAWNBiotechs
Is Day One Biopharmaceuticals (DAWN) Pricing Reflect Its Pipeline Progress And Cash Flow Potential
If you are wondering whether Day One Biopharmaceuticals is attractively priced or already reflects its potential, this article will walk through what the current market value might be saying.
The stock last closed at US$11.35, with a 7 day return of a 0.5% decline, a 30 day return of 5.8%, and a year to date return of 28.2%. The 1 year return sits at a 7.4% decline and the 3 year return at a 43.4% decline.
Recent news flow around Day One Biopharmaceuticals has focused on its progress as a...